Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanhui Liu

Showing results (571-580 of 584) with videos related to

Pageof 59
Sort By:
Human Mutation|July 10, 2019
LOVD-DASH: A comprehensive LOVD database coupled with diagnosis and an at-risk assessment system for hemoglobinopathiesLi Zhang, Qianqian Zhang, Yaohua Tang, et al.
Nature Communications|February 23, 2023
Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomasYanming Ren, Zongyao Huang, Lingling Zhou, et al.
European Journal of Human Genetics : EJHG|September 5, 2020
NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic studySumin Zhao, Wanyang Wang, Yaoshen Wang, et al.
European Journal of Human Genetics : EJHG|October 3, 2018
Pilot study of expanded carrier screening for 11 recessive diseases in China: results from 10,476 ethnically diverse couplesSumin Zhao, Jiale Xiang, Chunna Fan, et al.
Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.
Neuro-Oncology Advances|May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastomaGuanzhang Li, Xiaoguang Qiu, Wei Zhang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 6, 2021
CNV profiles of Chinese pediatric patients with developmental disordersHaiming Yuan, Shaofang Shangguan, Zhengchang Li, et al.
Molecular Cancer|July 25, 2022
CDC6 is a prognostic biomarker and correlated with immune infiltrates in gliomaFeng Wang, Fen Zhao, Li Zhang, et al.
Nature|December 20, 2019
The water lily genome and the early evolution of flowering plantsLiangsheng Zhang, Fei Chen, Xingtan Zhang, et al.
Cancer Letters|February 25, 2026
Clinical practice guidelines for the diagnosis and treatment of diffuse glioma-related epilepsy:2025 updateShuli Liang, Xing Fan, Suhui Kuang, et al.
Pageof 59

Showing results (571-580 of 584) with videos related to

Sort By:
Pageof 59
Human Mutation|July 10, 2019
LOVD-DASH: A comprehensive LOVD database coupled with diagnosis and an at-risk assessment system for hemoglobinopathiesLi Zhang, Qianqian Zhang, Yaohua Tang, et al.
Nature Communications|February 23, 2023
Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomasYanming Ren, Zongyao Huang, Lingling Zhou, et al.
European Journal of Human Genetics : EJHG|September 5, 2020
NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic studySumin Zhao, Wanyang Wang, Yaoshen Wang, et al.
European Journal of Human Genetics : EJHG|October 3, 2018
Pilot study of expanded carrier screening for 11 recessive diseases in China: results from 10,476 ethnically diverse couplesSumin Zhao, Jiale Xiang, Chunna Fan, et al.
Cancer Communications (London, England)|March 13, 2026
Vebreltinib for Previously Treated Astrocytoma, <i>IDH</i>-Mutant, Grade 4, and Glioblastoma, <i>IDH</i> Wild-Type with <i>PTPRZ1-MET</i> Fusion Gene: A Multicenter, Phase III Randomized, Open-Label TrialZhaoshi Bao, Yake Xue, Yanhui Liu, et al.
Neuro-Oncology Advances|May 29, 2026
An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastomaGuanzhang Li, Xiaoguang Qiu, Wei Zhang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 6, 2021
CNV profiles of Chinese pediatric patients with developmental disordersHaiming Yuan, Shaofang Shangguan, Zhengchang Li, et al.
Molecular Cancer|July 25, 2022
CDC6 is a prognostic biomarker and correlated with immune infiltrates in gliomaFeng Wang, Fen Zhao, Li Zhang, et al.
Nature|December 20, 2019
The water lily genome and the early evolution of flowering plantsLiangsheng Zhang, Fei Chen, Xingtan Zhang, et al.
Cancer Letters|February 25, 2026
Clinical practice guidelines for the diagnosis and treatment of diffuse glioma-related epilepsy:2025 updateShuli Liang, Xing Fan, Suhui Kuang, et al.
Pageof 59